512 related articles for article (PubMed ID: 26373345)
1. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
Gaj T; Epstein BE; Schaffer DV
Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
[TBL] [Abstract][Full Text] [Related]
2. Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing.
He X; Xie H; Liu X; Gu F
Hum Gene Ther; 2019 Jun; 30(6):673-681. PubMed ID: 30588843
[TBL] [Abstract][Full Text] [Related]
3. Genome engineering using Adeno-Associated Virus (AAV).
Howes R; Schofield C
Methods Mol Biol; 2015; 1239():75-103. PubMed ID: 25408402
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional AAV-CRISPR-Cas9 and its host response.
Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
[TBL] [Abstract][Full Text] [Related]
5. Adeno-Associated Virus-Mediated Delivery of CRISPR-Cas Systems for Genome Engineering in Mammalian Cells.
Gaj T; Schaffer DV
Cold Spring Harb Protoc; 2016 Nov; 2016(11):. PubMed ID: 27803249
[TBL] [Abstract][Full Text] [Related]
6. AAV Vectorization of DSB-mediated Gene Editing Technologies.
Moser RJ; Hirsch ML
Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
[TBL] [Abstract][Full Text] [Related]
7. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
8. Engineered Viruses as Genome Editing Devices.
Chen X; Gonçalves MA
Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery.
Gaj T; Staahl BT; Rodrigues GMC; Limsirichai P; Ekman FK; Doudna JA; Schaffer DV
Nucleic Acids Res; 2017 Jun; 45(11):e98. PubMed ID: 28334779
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.
Asuri P; Bartel MA; Vazin T; Jang JH; Wong TB; Schaffer DV
Mol Ther; 2012 Feb; 20(2):329-38. PubMed ID: 22108859
[TBL] [Abstract][Full Text] [Related]
11. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
12. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
14. High levels of AAV vector integration into CRISPR-induced DNA breaks.
Hanlon KS; Kleinstiver BP; Garcia SP; Zaborowski MP; Volak A; Spirig SE; Muller A; Sousa AA; Tsai SQ; Bengtsson NE; Lööv C; Ingelsson M; Chamberlain JS; Corey DP; Aryee MJ; Joung JK; Breakefield XO; Maguire CA; György B
Nat Commun; 2019 Sep; 10(1):4439. PubMed ID: 31570731
[TBL] [Abstract][Full Text] [Related]
15. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting.
Rahman SH; Bobis-Wozowicz S; Chatterjee D; Gellhaus K; Pars K; Heilbronn R; Jacobs R; Cathomen T
Hum Gene Ther; 2013 Jan; 24(1):67-77. PubMed ID: 23072634
[TBL] [Abstract][Full Text] [Related]
16. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
McCarty DM; Young SM; Samulski RJ
Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
Dong JY; Fan PD; Frizzell RA
Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
[TBL] [Abstract][Full Text] [Related]
18. Inverted terminal repeats of adeno-associated virus decrease random integration of a gene targeting fragment in Saccharomyces cerevisiae.
Galli A; Cervelli T
BMC Mol Biol; 2014 Feb; 15():5. PubMed ID: 24521444
[TBL] [Abstract][Full Text] [Related]
19. Targeted genome editing by recombinant adeno-associated virus (rAAV) vectors for generating genetically modified pigs.
Luo Y; Kofod-Olsen E; Christensen R; Sørensen CB; Bolund L
J Genet Genomics; 2012 Jun; 39(6):269-74. PubMed ID: 22749014
[TBL] [Abstract][Full Text] [Related]
20. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods.
Palaschak B; Herzog RW; Markusic DM
Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
